Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Access1
As we progress into 2022, the world continues its battle against COVID-19, with yet another new strain – Omicron, that…
Health Sciences Authority (HSA) is Singapore’s national authority regulating health products, including medications. Every month, HSA publishes a list of…
Disease burden and current treatment landscape Atopic dermatitis (AD) or atopic eczema is a common inflammatory skin condition that affects…
The Burden of Diabetic Kidney Disease Diabetes is the leading cause of kidney failure in Singapore, accounting for 66% of…
Migraines – A true pain to treat Migraine is a complex neurobiological disorder that has been recognised since antiquity. Its…
Health Sciences Authority (HSA) is Singapore’s national authority regulating health products, including medications. Every month, HSA publishes a list of…
The growing biologic armamentarium of plaque psoriasis treatment: A review of risankizumab (Skyrizi)
Psoriasis is an inflammatory immune-mediated chronic disease with significant impact on the individual’s physical, emotional and psychosocial wellbeing. The complex…
The Health Sciences Authority (HSA) is Singapore’s national authority regulating health products. Apart from approval of new drugs and indications,…
Myocarditis and pericarditis have been recognised as rare cardiac complications of COVID-19 mRNA vaccinations. Myocarditis is the inflammation of the…
Psoriasis is a common skin disease with a global prevalence of 2-3%, and affects over 40,000 people in Singapore. The…
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.